U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
199261199261Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 15 % Nitrous oxide|Drug: 0.3 % Sevoflurane|Drug: 30% Nitrous oxide|Drug: 0.6% Sevoflurane|Other: Placebohttps://ClinicalTrials.gov/show/NCT00000259
199262199262Role of Instructions in Nitrous Oxide Effects and Choice - 10CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Nitrous oxide 10% & placebo|Drug: Nitrous oxide 20% & placebo|Drug: Nitrous oxide 30% & placebo|Drug: Nitrous oxide 40% and placebohttps://ClinicalTrials.gov/show/NCT00000258
199263199263Effects of Alcohol History on Effects of Nitrous Oxide - 9CompletedNo Results AvailableAlcohol-Related Disorders|Opioid-Related Disorders|Substance-Related DisordersDrug: 0% N2O and 10% N2O|Drug: 0% N2O and 20% N2O|Drug: 0% N2O and 30% N2O|Drug: 0% N2O and 40% N2Ohttps://ClinicalTrials.gov/show/NCT00000257
199264199264Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 20% N2O|Drug: 40% N2O|Drug: 60% N2O|Drug: 80% N2Ohttps://ClinicalTrials.gov/show/NCT00000256
199265199265Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: Nitrous oxidehttps://ClinicalTrials.gov/show/NCT00000255
199266199266Isoflurane at Subanesthetic Concentrations - 6CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 40% Nitrous oxide|Other: Sham comparator|Drug: 0.2% isoflurane|Drug: 0.4% isoflurane|Drug: 0.6% isofluranehttps://ClinicalTrials.gov/show/NCT00000254
199267199267Effects of Nitrous Oxide: A Dose-Response Analysis - 5CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 10% N2O|Drug: 20% N2O|Drug: 30% N2O|Drug: 40% N2Ohttps://ClinicalTrials.gov/show/NCT00000253
199268199268Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 0% N2O|Drug: 10% N2O|Drug: 20% N2O|Drug: 30% N2O|Drug: 40% N2Ohttps://ClinicalTrials.gov/show/NCT00000252
199269199269Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 30% N2O|Drug: 0.2% isoflurane|Drug: 0.4% isofluranehttps://ClinicalTrials.gov/show/NCT00000251
199270199270Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 0% N2O|Drug: 40% N2Ohttps://ClinicalTrials.gov/show/NCT00000250
199271199271Effects of Subanesthetic Concentrations of Nitrous Oxide - 1CompletedNo Results AvailableOpioid-Related Disorders|Substance-Related DisordersDrug: 20% N2O|Drug: 30% N2O|Drug: 40% N2Ohttps://ClinicalTrials.gov/show/NCT00000249
199272199272Dose Response Trial of Pergolide for Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related DisordersDrug: Pergolidehttps://ClinicalTrials.gov/show/NCT00000248
199273199273Rapid Benzodiazepine Detoxification Using Flumazenil - 1CompletedNo Results AvailableSubstance-Related DisordersDrug: Flumazenilhttps://ClinicalTrials.gov/show/NCT00000246
199274199274Evaluation of a Desipramine Ceiling in Cocaine Abuse - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Desipraminehttps://ClinicalTrials.gov/show/NCT00000245
199275199275Effects of Dynorphin 1-13 on Heroin Addiction - 1CompletedNo Results AvailableOpioid-Related Disorders|Substance Withdrawal SyndromeDrug: Dynorphin 1 - 13https://ClinicalTrials.gov/show/NCT00000244
199276199276Effects of Buprenorphine/Naloxone in Treating Opioid Dependent Individuals Who Are Maintained on MethadoneTerminatedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000243
199277199277Carbamazepine Treatment of Cocaine Dependence - 1CompletedNo Results AvailableCocaine-Related Disorders|Substance-Related DisordersDrug: Carbamazepinehttps://ClinicalTrials.gov/show/NCT00000242
199278199278Flupenthixol Decanoate in Methamphetamine Smoking - 1CompletedNo Results AvailableSubstance-Related DisordersDrug: Flupenthixolhttps://ClinicalTrials.gov/show/NCT00000241
199279199279Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22CompletedNo Results AvailableCocaine-Related Disorders|Opioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000240
199280199280Buprenorphine Pharmacology Related to Addiction Treatment - 21CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000239
199281199281Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000238
199282199282Buprenorphine Detoxification - BBDVI - 19CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000237
199283199283Buprenorphine Pharmacology Related to Addiction Treatment - 18CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphine/naloxonehttps://ClinicalTrials.gov/show/NCT00000236
199284199284Alternate Day Buprenorphine Administration, Phase XII - 17CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000235
199285199285Alternate Day Buprenorphine Administration, Phase XI - 16CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000234
199286199286Alternate Day Buprenorphine Administration, Phase X - 15CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000233
199287199287Alternate Day Buprenorphine Administration, Phase IX - 14CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000232
199288199288Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000231
199289199289Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000230
199290199290Buprenorphine Detox With Two Types of Treatment. BBD II - 11CompletedNo Results AvailableOpioid-Related DisordersDrug: Buprenorphinehttps://ClinicalTrials.gov/show/NCT00000229

* Görseller ve İçerik tekif hakkına sahip olabilir